Services

In-depth guides and plain-language context

Our guides organize the basic questions around ibogaine and fentanyl addiction: what people mean by detoxification, what claims are being made, and what information remains uncertain. A review of what ibogaine does can help distinguish discussion of a substance from evidence of a treatment outcome.

For an overview of the resource’s purpose, sourcing approach, and limits, see how Moksha Circuit approaches independent information. The National Institute on Drug Abuse’s fentanyl information also describes why fentanyl’s potency and overdose risk demand careful, evidence-based context.

Comparisons and decision frameworks

Comparisons are designed to slow down easy answers. They place different information sources, treatment-setting descriptions, and legal claims side by side without ranking clinics or recommending an intervention. Readers considering location-specific material can review context about an ibogaine clinic in Tijuana alongside broader descriptions of ibogaine detox centers.

Legal status is not a safety endorsement, and availability is not proof of effectiveness. Our framework includes the question of whether ibogaine is illegal, because regulation varies by jurisdiction and may affect what claims, safeguards, and avenues of recourse are relevant.

Research summaries and safety context

Research summaries separate what a study observed from what it can establish. They note study design, population, limitations, and the difference between early signals and established care. Ibogaine is discussed in the reference overview of ibogaine as a psychoactive alkaloid, but that description does not resolve the clinical and safety questions relevant to fentanyl use.

Descriptions of ibogaine treatments in Mexico and material on ibogaine clinics are best read as context to investigate, not as verification of safety or quality. The U.S. Food and Drug Administration’s drug development and approval process provides useful context for why evidence and authorization are separate questions.

Practical FAQ collections

FAQ collections gather recurring questions into a usable sequence: terminology, evidence limits, safety concerns, regulation, and what information is still needed. They are meant to support careful conversations, not replace assessment by qualified professionals. Readers can return to the main fentanyl and ibogaine resource when they need the broader framework around these questions.